Answers are grounded in this paper and cite their sources.
In campaign 1, 124.3 kg of 2-methyl-5-(2H-1,2,3-triazol-2-yl)pyridine N-oxide (8) was prepared in 2 stages from 5-bromo-2-methylpyridine. The first stage was a regioselective copper-catalyzed Ullmann reaction using 1H-1,2,3-triazole. The second stage was an oxidation with peracetic acid to form the corresponding pyridine N-oxide. In campaign 2, 223.8 kg of 2-methyl-5-(2H-1,2,3-triazol-2-yl)pyridine N-oxide (8) was prepared. An alternative palladium-catalyzed Buchwald−Hartwig approach using Me4tBuXPhos as a ligand was developed but not scaled up. 2-Methyl-5-(2H-1,2,3-triazol-2-yl)pyridine N-oxide (8) is a key intermediate in the synthesis of the orexin 1 receptor antagonist C4X3256.
No takes yet. Share an insight, caveat, or question.
Carey et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: